10X Genomics Inc (TXG) Stock Analysis

10X Genomics Inc (TXG) is a publicly traded company in the HEALTHCARE sector. It trades at $30.71, carries a market capitalization of $3.76B. This page summarizes the public market data, fundamentals, and frequently asked questions for TXG, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

10X Genomics Inc currently has a Neutral sentiment score of -0.04.

About 10X Genomics Inc

10X Genomics, Inc. is a premier life science technology company focused on delivering innovative genomic analysis solutions that empower researchers to dissect complex biological systems. With a comprehensive suite of advanced instruments, consumables, and analytical software, the company enhances the resolution and accuracy of genetic research. Operating from its headquarters in Pleasanton, California, 10X Genomics serves a diverse global market, catering to the dynamic needs of life science...

GNG Research Analysis

GNG Research scores 10X Genomics Inc (TXG) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TXG.

Frequently Asked Questions

Does TXG pay dividends?

10X Genomics Inc (TXG) does not currently pay a regular dividend.

What is TXG's market cap?

10X Genomics Inc (TXG) has a market capitalization of $3.76B with a current stock price of $30.71.